All News

The FDA action was based on results from the Phase 3 CheckMate -9ER trial evaluating nivolumab in combination with cabozantinib compared with sunitinib among patients with previously untreated advanced RCC.

After a rewarding 40-year career, Pharmacy Quality Solutions CEO Jeff Newell announces intent to retire in 2021.

Dogs and Cats have different blood make-ups and need a specifically calibrated device for glucose monitoring to manage diabetes.

Venetoclax was granted accelerated approval in November 2018, as well as priority review, breakthrough designation, and orphan drug designation.

In a short time, COVID-19 has increased our dependency on technology and pharmaceutical companies are actively investigating this digital transformation.

Top news of the week from Pharmacy Times.

A recent study found that where you live affects the risk of chronic conditions, such as high blood pressure and depression.

Women found to have worse outcomes after a first heart attack than men.

Women diagnosed with cancer as adolescents or young adults can be especially vulnerable to the impact of the disease and its treatment on their ability to work.

Which poisonous chemical was historically infused into chalices to induce vomiting?

Atoltivimab, maftivimab, and odesivimab-ebgn (Inmazeb), a monoclonal antibody cocktail ffor the treatment of adult and pediatric patients with Ebola virus infection, becomes the first drug approved to treat Ebola virus.

The FDA approved an expanded label for for pembrolizumab for adult patients with relapsed or refractory classical Hodgkin lymphoma.

Hospitalized patients with COVID-19 treated with enoxaparin were found to have lower rates of thrombosis, kidney injury, and mortality than patients treated with unfractionated heparin.

Age has been connected to symptom severity and mortality in COVID-19, however, it does not affect susceptibility to infection with the virus.

Although researchers still hope to learn what protection immunoglobulin G antibodies offer against re-infection, this study could have broad implications in the development of a COVID-19 vaccine.

Due to the suboptimal rates of live-attenuated varicella vaccination, outbreaks of varicella-zoster virus still occur, causing incidence of both varicella and herpes zoster.

One in 4 adults reported a change in alcohol use almost immediately after stay-at-home orders were issued during the coronavirus disease 2019 pandemic.

Copanlisib (Aliqopa) in combination with rituximab (Rituxan) prolonged progression-free survival in patients with non-Hodgkin lymphoma who relapsed following 1 or more previous lines of rituximab-based therapy.

The combination of isolating potentially sick patients in their car and conducting the test in a ventilated setting minimizes COVID-19 transmission to the rest of the population.

The National Community Pharmacists Association's annual convention is scheduled to take place virtually October 18-19, 2020.

The physical and emotional stress of a COVID-19 diagnosis might be the triggering factor for the development of herpes zoster ophthalmicus.

Investigators found a link between the sleep quality of mother and child related to the COVID-19 pandemic.

Despite it being fall, sun safety is important all year and even needs to be considered for winter sport activities, such as snowboarding and skiing.

Evidence-based cancer regimens have been shown to result in better outcomes, including longer survival and less toxicity.

Higher rates of mental health symptoms were found among younger respondents, those who identified themselves as female, and those who reported having a pre-existing mental health condition.

Some of these behaviors are not considered indicators of Alzheimer disease or other memory-impairing illnesses.

The importance of a team-based approach including pharmacy staff in performing medication reconciliation during a transition of care for patients being discharged from the hospital.

Pacritinib is a JAK2/FLT3 inhibitor for the treatment of patients with myelofibrosis and severe thrombocytopenia defined as platelet counts of less than 50,000 μL.